Dr Ashu Kumar Jain
Many cancer patients expect tiredness, nausea, or hair loss during chemotherapy. Fewer are prepared for burning, tingling, numbness, or electric pain in the hands and feet. This can happen when chemotherapy affects the peripheral nerves, a condition often called chemotherapy-induced peripheral neuropathy, or CIPN. It can disturb sleep, affect walking, make daily tasks difficult, and sometimes continue even after chemotherapy is complete.
What Is Chemotherapy-Induced Peripheral Neuropathy?
Peripheral nerves are the nerves outside the brain and spinal cord. They carry signals for sensation, movement, balance, temperature, and pain.
Some chemotherapy medicines can irritate or damage these nerves. When this happens, the nerves may send abnormal signals such as burning, tingling, numbness, stabbing pain, or electric-shock-like sensations.
This is called chemotherapy-induced peripheral neuropathy. It most commonly affects the hands and feet because the longest nerves in the body are often the most vulnerable.
Why Do Hands and Feet Get Affected?
The nerves going to the toes and fingers are long and delicate. When chemotherapy affects nerve function, symptoms often begin at the ends of these nerves first.
Patients may notice tingling in the toes, burning in the soles, numb fingertips, or difficulty feeling temperature. Over time, symptoms may move upward in a stocking-and-glove pattern.
This pattern matters because it helps distinguish chemotherapy-related nerve pain from pain coming from a single joint, muscle, or spine level.
What Does Chemo-Related Nerve Pain Feel Like?
Patients describe chemotherapy-related nerve symptoms in different ways. Some feel burning. Some feel pins and needles. Some feel numbness, tightness, cold sensitivity, or pain from light touch.
The symptoms may be worse at night, after walking, or when the feet are resting. Hand symptoms may make it difficult to button clothes, write, hold utensils, use a phone, or handle small objects.
Pain is not the only concern. Numbness and reduced sensation can increase the risk of falls, burns, cuts, and unnoticed injuries.
- Burning pain in the feet or hands
- Tingling, pins and needles, or crawling sensations
- Numbness or reduced ability to feel temperature
- Electric-shock-like or stabbing pain
- Pain from light touch, socks, shoes, or bedsheets
- Balance difficulty or unsteadiness while walking
- Trouble gripping, writing, buttoning clothes, or using small objects
Can Symptoms Continue After Chemotherapy Ends?
Yes. In some patients, nerve symptoms improve gradually after chemotherapy is completed. In others, symptoms may continue for months or longer.
Nerves heal slowly. If the nerve irritation has been significant, recovery may take time. Some patients also notice that symptoms become more obvious after treatment ends because the focus shifts from cancer treatment survival to daily function and comfort.
Persistent symptoms should be discussed with the oncology team and a pain specialist. The goal is to reduce suffering while protecting function and safety.
"After chemotherapy, burning or tingling in the hands and feet should not be dismissed as weakness. It may be nerve pain, and it deserves proper evaluation."
Why It Should Not Be Ignored
Chemotherapy-related neuropathy can affect more than comfort. If the feet are numb or painful, walking may become unsafe. If the hands are numb, cooking, writing, driving, or handling medicines may become harder.
Reduced sensation can also make patients less aware of injuries. A small cut, burn, or shoe bite may go unnoticed, especially in patients who also have diabetes or poor circulation.
Early reporting helps the medical team adjust care, reduce risk, and plan symptom treatment before function declines further.
When Should You Tell Your Doctor?
Tell your oncologist or treating doctor if you develop new burning, tingling, numbness, weakness, balance difficulty, or hand clumsiness during or after chemotherapy.
You should seek prompt evaluation if symptoms are rapidly worsening, affecting walking, causing falls, preventing sleep, or making daily activities difficult.
Also report wounds, swelling, colour change, fever, severe weakness, or sudden loss of sensation.
How Is It Evaluated?
Evaluation begins with the symptom pattern. The doctor will ask when symptoms started, whether they affect hands, feet, or both, whether they are painful or numb, and how they affect daily life.
A physical examination may check sensation, reflexes, strength, balance, walking pattern, and skin condition. Blood tests may be needed to look for other contributors such as vitamin deficiency, thyroid disease, diabetes, kidney problems, or other causes of neuropathy.
The diagnosis is not made from one symptom alone. It comes from matching the cancer treatment history with the nerve symptom pattern and examination findings.
What Treatments Can Help?
The oncology team remains central to cancer treatment, but persistent burning, tingling, numbness, or electric pain is where a pain medicine physician can add a different layer of care. At Jain Pain Clinic, Dr Ashu Kumar Jain coordinates with the patient's oncologist while evaluating the pain as a neuropathic pain condition in its own right.
The first step is to confirm that the symptoms fit chemotherapy-induced neuropathic pain and to make sure there is no other causative agent such as diabetes, vitamin deficiency, thyroid disease, kidney problems, spine-related nerve compression, or medication-related neuropathy. Once the pain generator is clearer, treatment can move beyond general reassurance or routine painkillers.
Medical management may include neuropathic medicines that calm abnormal nerve signals, such as pregabalin or gabapentin, duloxetine, or tricyclic medicines such as Tryptomer, amitriptyline, or nortriptyline. These medicines should be individualised by a pain physician based on pain severity, sleep disturbance, kidney function, age, other medicines, and side effects.
Physiotherapy, balance training, hand exercises, foot care, fall prevention, and sleep support can also make a major difference. If symptoms remain uncontrolled despite medical management and rehabilitation, interventional pain procedures may be considered for selected patients. These may include dorsal nerve root ganglion ablation, sympathetic blocks, or sympathectomy, depending on the pattern and severity of neuropathic pain.
- Coordinate with the oncologist while assessing the pain pattern separately
- Rule out other causes of neuropathy such as diabetes, vitamin deficiency, thyroid disease, kidney disease, or spine-related nerve compression
- Optimise neuropathic medicines such as pregabalin, gabapentin, duloxetine, or tricyclic medicines such as Tryptomer under medical supervision
- Use physiotherapy, balance training, and hand or foot protection to preserve function
- Consider interventional pain options such as dorsal nerve root ganglion ablation, sympathetic blocks, or sympathectomy when symptoms remain severe despite standard care
Daily Safety Tips for Hands and Feet
When sensation is reduced, prevention becomes important. Check the feet daily for cuts, blisters, redness, swelling, or shoe pressure marks.
Use comfortable footwear, avoid walking barefoot, and be careful with hot water, heating pads, and kitchen heat because reduced sensation can make burns easier.
For hand symptoms, use caution with sharp objects, hot utensils, and tasks that require fine grip. Small adjustments can prevent injuries while the nerves recover.
The Takeaway
Burning, tingling, numbness, or electric pain in the hands and feet after chemotherapy may be chemotherapy-induced peripheral neuropathy.
It is not simply weakness, and it should not be ignored if it affects walking, sleep, balance, hand function, or safety. Once the oncology team has reviewed the cancer-treatment side, a pain medicine physician can focus specifically on the neuropathic pain pathway.
At Jain Pain Clinic in Gurugram, Dr Ashu Kumar Jain evaluates chemotherapy-related neuropathic pain from a pain medicine perspective: confirming the pain pattern, optimising neuropathic medicines, and considering targeted interventional procedures when symptoms remain uncontrolled.